Regulation of mediator release by human basophils: importance of the sequence and time of addition in the combined action of different agonists.
Biologically active molecules affecting basophil function can be divided into 4 groups according to their capacity to induce basophil degranulation and/or leukotriene generation: (1) full agonists such as anti-IgE or fMLP, which induce both histamine and leukotriene release; (2) partial agonists such as C5a, which induces degranulation only; (3) incomplete agonists such as neutrophil-activating peptide-1, platelet-activating factor or C3a, which induce mediator release only after cytokine preincubation, and (4) basophil response modifiers, such as interleukin-3, interleukin-5 and granulocyte/macrophage- colony-stimulating factor, which (a) enhance the releasability to all basophil agonists, (b) change the mediator profile, (c) enhance the rate of mediator release, (d) render basophils responsive to lower agonist concentrations and (e) render basophils responsive to incomplete agonists. We demonstrated that histamine release and de novo synthesis of lipid mediators are clearly separately regulated, and that combined actions of different molecules are of importance. In particular, the type(s), the time interval and the sequence of action of basophil-activating molecules are crucial for the final outcome of the basophil release reaction.
Dahinden
C A
CA
Institute of Clinical Immunology, Inselspital, University of Berne, Switzerland.
Bischoff
S C
SC
Brunner
T
T
Krieger
M
M
Takafuji
S
S
de Weck
A L
AL
D001491:Basophils / Q000187:drug effects / Q000378:metabolism*; D015936:Complement C5a / Q000494:pharmacology; D016207:Cytokines / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D016209:Interleukin-8 / Q000494:pharmacology; D013189:SRS-A / Q000096:biosynthesis*
D016207:Cytokines; D007377:Interleukin-3; D016209:Interleukin-8; D013189:SRS-A; D015936:Complement C5a